Could global regulators miss another Archegos whale?

Spotting systemic risk from OTC swaps requires cross-border access to derivatives data

When Archegos Capital Management collapsed, inflicting more than $10 billion in losses on prime brokers, the extent of its multi-billion-dollar portfolio of total return swaps (TRS) caught banks and regulators off-guard.

And while the family office’s demise may not have threatened financial stability, it did expose holes in the supervisory net that purports to capture global derivatives markets – and sounded a warning that a repeat episode could inflict much greater damage.


Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here